Navigation Links
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
Date:7/7/2009

/a> a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company                Contact: Investor Relations
    Stephen B. Thompson             Donald C. Weinberger/Diana Bittner (media)
    Vice President                  Wolfe Axelrod Weinberger Assoc. LLC
    Chief Financial Officer        (212) 370-4500
    Access Pharmaceuticals, Inc.
    (214) 905-5100


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
7. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
8. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... fiduciary duties to shareholders or violated the federal securities ... disclosed: "On September 11, 2014, [PDL] was orally notified ... LLP ("EY"), that it was resigning effective September 11, ...
(Date:9/19/2014)... /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... report firstly reviews the basic information of ... manufacturing technology. The report then explores global ... listing their product specification, capacity, Production value, ...
(Date:9/19/2014)... CHICAGO, Ill. , Sept. 19, 2014  The ... ABBV ) declared a quarterly cash dividend of $0.42 ... payable Nov. 17, 2014 to stockholders of record at ... About AbbVie AbbVie is a global, research-based biopharmaceutical ... company,s mission is to use its expertise, dedicated people ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5
... of Orange Park is hosting a car wash to raise money ... AM at the Hooters of Orange Park located at 1740 Wells ... from the car wash will go toward the Kelly Jo Dowd ... the country is raising money through various charitable efforts in the ...
... Reinforce March of Dimes Message: Start Taking a Vitamin ... Women who take folic acid supplements for at ... their risk of having a premature baby by half, ... journal, PLOS Medicine.The study links pre-conceptional folate supplementation of ...
Cached Medicine Technology:Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth 2
(Date:9/20/2014)... The Arizona Advanced Manufacturing ... National Manufacturing Day by opening its doors to the ... additive manufacturing labs will be offered between 10 a.m. ... Southern and Dobson campus (1833 W. Southern Ave, Mesa, ... , The AzAMI at MCC was established in the ...
(Date:9/20/2014)... “Motherhood is a wonderful gift and a huge responsibility,” ... article , “We know that you want to care for ... want to do as well.” , The article explains to ... their Family Physicians who practice obstetrics while pregnant, during delivery, ... To learn more about Community Health Center of Snohomish County ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The children ... the balanced and active play they need. An empty ... Center - Lakeview Campus was transformed into a kid-designed ... of 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney ... , KaBOOM! believes a playground is more than a ...
(Date:9/19/2014)... York, NY (PRWEB) September 20, 2014 ... moderate revenue growth for the Vision Insurance industry ... pace, to the detriment of industry margins. From ... noticeably increase. Industry operators provide coverage for routine ... discounted pricing for eyeglasses, contact lens and refractive ...
(Date:9/19/2014)... 19, 2014 Are you tired of ... problems with seasonal allergies or sinus congestion? Fortunately, an ... alternative. , She conceived of Nose Pal to ... runny nose in public. Since it prevents nasal drip ... sanitary conditions, particularly when cooking or working closely with ...
Breaking Medicine News(10 mins):Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2
... with Autism is the focus of the research of one ... Economic and Social Research Council (ESRC) and the Young Foundation. ... the causes of autism rather than understanding it as a ... over a period of three years Dr Elizabeth Pellicano, from ...
... Lady Laura Bush,today saluted the U.S. Department of ... Prevention Initiative, announced today at,the National Prevention Summit, ... weight for children., Mrs. Bush delivered the ... event that highlights new approaches to prevention,and health ...
... Ventas, Inc. (NYSE:,VTR) ("Ventas" or the "Company") said ... dividend of $0.475 per share, payable in cash,on December ... 2007. The,dividend is the fourth quarterly installment of the ... quarterly installment of the Company,s 2007 annual dividend,will be ...
... bizarre behaviors and sudden deaths , , TUESDAY, Nov. ... Drug Administration advisory panel recommended Tuesday that the prescription ... label to reflect reports of bizarre behaviors and deaths ... a 9-5 vote, said that drug maker Roche Holding ...
... SAN DIEGO, Nov. 27 Gen-Probe Incorporated,(Nasdaq: GPRO ... the NASDAQ,20th Investor Program in London on Thursday, December ... a.m. Eastern Time). The,presentation is scheduled to be webcast ... investor information section of Gen-Probe,s website at, http://www.gen-probe.com . ...
... Address Growing Healthcare Trends and the Tools Health Plans ... ... Portico Systems, the leader in,Provider Network Management solutions, will host a ... practices for,provider network management. The complimentary series starts Tuesday,December 4th, showcasing ...
Cached Medicine News:Health News:Autism focus of prize winning research 2Health News:HHS Launches Childhood Overweight and Obesity Prevention Initiative 2Health News:HHS Launches Childhood Overweight and Obesity Prevention Initiative 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 4Health News:FDA Panel Backs Stronger Warning for Tamiflu 2Health News:FDA Panel Backs Stronger Warning for Tamiflu 3Health News:Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program 2Health News:Portico Systems Offers Webinar Series to Share Provider Network Management Best Practices 2
30 Degree Angle Shaft with 1.0mm 90 Degree Angle Tip; in stainless steel....
0.5mm "K" hook. Rounded knurled handle; shaft angled 11mm from tip; overall length 120mm, in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
Medicine Products: